Home Cart Sign in  
Chemical Structure| 1802977-61-2 Chemical Structure| 1802977-61-2

Structure of GNE-140 racemate
CAS No.: 1802977-61-2

Chemical Structure| 1802977-61-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

GNE-140 racemate is a LDHA inhibitor.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of GNE-140 racemate

CAS No. :1802977-61-2
Formula : C25H23ClN2O3S2
M.W : 499.04
SMILES Code : O=C(C1SC2=CC=CC=C2Cl)NC(C3=CSC=C3)(C4=CC=C(N5CCOCC5)C=C4)CC1=O
MDL No. :MFCD30489754
InChI Key :GLDDJXYFHWRGPI-UHFFFAOYSA-N
Pubchem ID :118384725

Safety of GNE-140 racemate

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Th17 cells 10 μM 3 days GNE-140 could decrease the percentage of IL-17+CD4 T cells, suggesting the suppressor role of GNE-140 on Th17 differentiation in Bcl-3-/- mice Front Immunol. 2022 Sep 9;13:929785
MDA-MB-231 cells 50 μM 24 hours to 7 days To evaluate the effects of GNE-140 on lactic acid production, glucose utilization, and cell proliferation in MDA-MB-231 cells. Results showed that GNE-140 effectively blocked lactic acid production, inhibited glucose utilization and cell proliferation, but had no adverse effects on cell viability or mitochondrial membrane potential. Biomolecules. 2021 Nov 24;11(12):1751
rat alveolar bone marrow mesenchymal cells (ABMMCs) 10 μM 24 hours Inhibition of lactate dehydrogenase A (LDHA) activity, reducing lactate production, thereby suppressing osteogenic differentiation, proliferation, and migration of ABMMCs, and enhancing apoptosis. Cells. 2022 Nov 22;11(23):3724
LS174T human colorectal adenocarcinoma cells 10 µM 24 hours To evaluate the inhibitory effect of GNE-140 on LDH activity and its impact on HSP expression. Results showed that GNE-140 significantly reduced LDH activity in LS174T cells and downregulated the expression of Hsp90, Hsp70, and Hsp27. Cancers (Basel). 2021 Jul 27;13(15):3762

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Triple-negative breast cancer (TNBC) and non-small cell lung cancer (NSCLC) models Intraperitoneal injection 100mg/kg Single dose, effects observed after 30 minutes GNE-140 significantly reduced the lactate signal in breast and lung cancer models within 30 minutes, decreasing the lactate-to-pyruvate ratio by approximately 80%. NMR Biomed. 2021 Aug;34(8):e4560

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.00mL

0.40mL

0.20mL

10.02mL

2.00mL

1.00mL

20.04mL

4.01mL

2.00mL

References

 

Historical Records

Categories